Health ministry considers raising the public price of drugs due to calculation errors, increasing reverse billing due to high costs
採算割れの薬の公定価格引き上げ、厚労省検討 コスト高で逆ざや増加
Reports
- 採算割れの薬の公定価格引き上げ、厚労省検討 コスト高で逆ざや増加Health ministry considers raising the public price of drugs due to calculation errors, increasing reverse billing due to high costsassets.wor.jp · ja ·